Showing results (1411-1420 of 1,788) with videos related to

Sort By:
Pageof 179
Hepatology Communications|December 31, 2021
Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLDJoana Vieira Barbosa, Scott Milligan, Andrew Frick, et al.
Hepatology Communications|December 24, 2021
Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty LiverIndu G Rajapaksha, Lakmie S Gunarathne, Khashayar Asadi, et al.
Hepatology Communications|November 5, 2021
Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular CarcinomaQuan Chen, Austin Z Chen, Guorong Jia, et al.
Hepatology Communications|October 20, 2022
Serum keratin-18 detects hepatic inflammation and predicts progression in compensated alcohol-associated liver diseaseKatrine Holtz Thorhauge, Maja Thiele, Sönke Detlefsen, et al.
Hepatology Communications|November 5, 2022
Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS studyAnne-Marieke van Dijk, Yasaman Vali, Anne Linde Mak, et al.
Hepatology Communications|October 10, 2022
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based modelAnahita Rabiee, Yanhong Deng, Maria Ciarleglio, et al.
Hepatology Communications|October 12, 2022
HCV direct acting antiviral treatment leads to highly durable rates of ALT and AST lower than 30/19 criteria and improved APRI and FIB-4 scoresTung Huynh, Stephanie Ma, Ke-Qin Hu
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Hepatology Communications|March 8, 2021
Effectiveness of a Decentralized Hub and Spoke Model for the Treatment of Hepatitis C Virus in a Federally Qualified Health CenterSarah A Rojas, Job G Godino, Adam Northrup, et al.
Hepatology Communications|March 8, 2021
Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated CirrhosisMaya Balakrishnan, Caroline Falker, Samantha Conley, et al.
Pageof 179